Gene · 5798
Papers3,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Oxylipin-Related Nutrient Pattern and Risk of Type 1 Diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). | Nutrients | 2023 | 36839302 | PubTator, text mining | PubMed |
| The Pathogenic Diagnosis in Pediatric Diabetology: Next Generation Sequencing and Precision Therapy. | Medicina (Kaunas) | 2023 | 36837511 | PubTator, text mining | PubMed |
| The Mutation Spectrum of Rare Variants in the Gene of Adenosine Triphosphate (ATP)-Binding Cassette Subfamily C Member 8 in Patients with a MODY Phenotype in Western Siberia. | J Pers Med | 2023 | 36836406 | PubTator, text mining | PubMed |
| The Distribution of Autoantibodies by Age Group in Children with Type 1 Diabetes versus Type 2 Diabetes in Southern Vietnam. | J Clin Med | 2023 | 36835954 | PubTator, text mining | PubMed |
| Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? | Cancers (Basel) | 2023 | 36831689 | PubTator, text mining | PubMed |
| Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example. | Semin Immunol | 2023 | 36827760 | PubTator, text mining | PubMed |
| Evaluation of polygenic risk scores to differentiate between type 1 and type 2 diabetes. | Genet Epidemiol | 2023 | 36821788 | PubTator, text mining | PubMed |
| Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma. | Ann Transl Med | 2023 | 36819551 | PubTator, text mining | PubMed |
| Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus. | Cureus | 2023 | 36819400 | PubTator, text mining | PubMed |
| Circulating biomarkers during progression to type 1 diabetes: A systematic review. | Front Endocrinol (Lausanne) | 2023 | 36817583 | PubTator, text mining | PubMed |
| Construction and validation of a cuproptosis-related prognostic model for glioblastoma. | Front Immunol | 2023 | 36814929 | PubTator, text mining | PubMed |
| Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes. | Diabetes Care | 2023 | 36802355 | PubTator, text mining | PubMed |
| Maturity-onset diabetes of the young secondary to HNF1B variants (HNF1B-MODY): a series of 10 patients from a single diabetes center. | Diabetol Metab Syndr | 2023 | 36793123 | PubTator, text mining | PubMed |
| The impact of fear of hypoglycaemia on sleep in adolescents with type 1 diabetes. | Diabet Med | 2023 | 36786042 | PubTator, text mining | PubMed |
| De novo HNF1A mutation of young maturity-onset diabetes 3 of a young girl-Case report. | BMC Endocr Disord | 2023 | 36782183 | PubTator, text mining | PubMed |
| The phenotype of type 1 diabetes in sub-Saharan Africa. | Front Public Health | 2023 | 36778553 | PubTator, text mining | PubMed |
| BCG-induced trained immunity: history, mechanisms and potential applications. | J Transl Med | 2023 | 36765373 | PubTator, text mining | PubMed |
| Glucokinase maturity-onset diabetes of the young as a mimicker of stress hyperglycemia: a case report. | Clin Pediatr Endocrinol | 2023 | 36761491 | PubTator, text mining | PubMed |
| Effects of once-weekly dulaglutide on juvenile type 2 diabetes mellitus and obesity in Korea: a pilot study. | Ann Pediatr Endocrinol Metab | 2023 | 36758973 | PubTator, text mining | PubMed |
| Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study. | PLoS One | 2023 | 36758065 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5798/papers?page=16